|Day Low/High||4.10 / 4.50|
|52 Wk Low/High||0.20 / 5.85|
- Company to Host Fourth Quarter 2016 Financial Results and Commercial Update Conference Call on Tuesday, March 7, 2017 at 11:00 AM ET -
vBloc® Therapy Demonstrates Significant and Sustained Weight Loss and Glycemic Control in Obese Patients with Type 2 Diabetes
Breadth has improved quite a bit, but it is a challenge to find new inventory.
Traders, pressed to find some action, are chasing certain things to a ridiculous extent.
With poor breadth and money managers hiding in large-caps, I am being cautious, right now.
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
Key Element of Plan to Regain Nasdaq Listing Compliance
TheStreet's biotech columnist offers his own report card on biotech stocks.
vBloc Institute Data Corroborates Pivotal Clinical Trial Results at Six and Nine Months
- Company to hold conference call today at 11:00 AM Eastern Time -
- Company to hold conference call November 30, 2016 at 11:00 AM Eastern Time -
EnteroMedics' Chief Medical Officer to Co-Moderate Neuromodulation Panel
- vBloc® Therapy Demonstrates Durable Weight Loss, Reduction of Comorbidities, and Favorable Safety Profile at 24 Months -